$CADL 8-K SEC Filings

Filed On	Filing
10 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure Regulatory and quality expertise strengthens Board as Candel advances toward planned Biologics License Application (BLA) submission and potential commercial readiness
09 Sep 2026	8-K: Regulation FD Disclosure Exhibit 99.1 Tipping the balance in favor of the immune system to fight cancer NASDAQ: CADL Corporate Presentation \| September 2026 © © 2026 2026 by by C Ca an ndel del T Ther hera ap peu eut ti ic cs s
13 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
16 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
15 May 2026	8-K: Regulation FD Disclosure
14 May 2026	8-K: Results of Operations and Financial Condition
12 Mar 2026	8-K: Results of Operations and Financial Condition
23 Feb 2026	8-K: Entry into a Material Definitive Agreement; Other Events
19 Feb 2026	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more
05 Dec 2025	8-K: Regulation FD Disclosure
13 Nov 2025	8-K: Results of Operations and Financial Condition
14 Oct 2025	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +4 more
21 Aug 2025	8-K: Entry into a Material Definitive Agreement
14 Aug 2025	8-K: Results of Operations and Financial Condition
24 Jun 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
23 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
18 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
06 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
28 May 2025	8-K: Regulation FD Disclosure; Other Events

Comments